Information Provided By:
Fly News Breaks for January 31, 2020
Jan 31, 2020 | 06:24 EDT
JPMorgan analyst Jeffrey Zekauskas upgraded Corteva to Neutral from Underweight with a price target of $29, up from $26. The analyst says Corteva ended 2019 with a "far stronger" balance sheet than he had envisioned because of "excellent" cash generation in Q4. This improved the company's enterprise value to EBITDA valuation multiple by a half point, Zekauskas tells investors in a research note. The current price of Corteva of $29 now reflects an 11.5 times multiple based on the revised enterprise value for 2020, says the analyst. He views the valuation as fair at current levels.
News For CTVA From the Last 2 Days
There are no results for your query CTVA